Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>>NEW! Download now...

Tiantan Building Large Vaccine Facility in BDA

publication date: Jun 4, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Beijing Tiantan Biological Products, a biopharmaceutical company, is developing a 2.7 billion RMB ($400 million) biological vaccine production facility in the Beijing Economic-Technological Development Area (BDA). The company makes vaccines, blood-related products and diagnostic devices. One of its major product lines is hepatitis B vaccines. More details...

Stock Symbol: (SHSE: 600161)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events


BioPacific Conference 2012
June 2, 2012
California, USA

  China Forum 2012
  November 11, 2012
Hamburg, Germany

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners